ASX Small Cap Lunch Wrap: Investors could be in the eye of a storm

Last week was chaotic for investors as global stocks suffered their worst declines since March.

The spark — flaring COVID-19 numbers and an ‘edge-of-your-seat’ US presidential election – probably means this week won’t be any better.

The US election is due to be decided Wednesday (Aussie time).

Trump has consistently trailed challenger Biden in national polls for months, but polls have shown a closer race in the most competitive states.

And we all know what happened last time.

The Aussie market has fallen six of the past seven trading days, but still rose by 1.9 per cent in October thanks to a strong start to the month.

This morning, the new ASX website crapped the bed, again.

Still, we reckon the ASX 200 index was up about 0.33 per cent to 5,947.2 points to 12:15pm eastern time.

WINNERS

Here are the best performing ASX small cap stocks at 12pm Monday November 2:

Swipe or scroll to reveal the full table. Click headings to sort.

Ironbark Zinc (ASX:IBG) is closer to financing its big Citronen zinc-lead project in Greenland.

A non-binding letter of intent (LOI) was signed with the US Government’s export credit agency, which will consider financing up to ~$US216m of Citronen’s development costs.

Pharmaxis (ASX:PXS) shares soared after the United States Food and Drug Administration approved its inhaled dry powder formulation to treat cystic fibrosis.

And an incredible ‘best ever’ gold hit at Stavely Minerals’ (ASX:SVY) Cayley Lode discovery send the stock flying in morning trade.

LOSERS

Here are the worst performing ASX small cap stocks at 12pm Monday November 2:

Swipe or scroll to reveal the full table. Click headings to sort.